相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dipeptidylpeptidase Inhibition Is Associated with Improvement in Blood Pressure and Diastolic Function in Insulin-Resistant Male Zucker Obese Rats
Annayya R. Aroor et al.
ENDOCRINOLOGY (2013)
Significance of Matrix Metalloproteinase-9 Inhibition by Imidapril for Prevention of Abdominal Aortic Aneurysms in Angiotensin II Type 1 Receptor-Knockout Mice
Shinji Takai et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2013)
Glucose-independent improvement of vascular dysfunction in experimental sepsis by dipeptidyl-peptidase 4 inhibition
Swenja Kroeller-Schoen et al.
CARDIOVASCULAR RESEARCH (2012)
Comparative Clinical Pharmacokinetics of Dipeptidyl Peptidase-4 Inhibitors
Larry K. Golightly et al.
CLINICAL PHARMACOKINETICS (2012)
A Dipeptidyl Peptidase-4 Inhibitor, Des-Fluoro-Sitagliptin, Improves Endothelial Function and Reduces Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice
Junichi Matsubara et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs
K. R. Hjollund et al.
DIABETOLOGIA (2011)
Candesartan and amlodipine combination therapy provides powerful vascular protection in stroke-prone spontaneously hypertensive rats
Shinji Takai et al.
HYPERTENSION RESEARCH (2011)
Acute DPP-4 inhibition modulates vascular tone through GLP-1 independent pathways
Zubair Shah et al.
VASCULAR PHARMACOLOGY (2011)
Glucagon-Like Peptide 1 Prevents Reactive Oxygen Species-Induced Endothelial Cell Senescence Through the Activation of Protein Kinase A
Hisko Oeseburg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
Masayuki Arakawa et al.
DIABETES (2010)
Dipeptidyl-Peptidase 4 and Attractin Expression is Increased in Circulating Blood Monocytes of Obese Human Subjects
M. Laudes et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2010)
Increased Plasma Dipeptidyl Peptidase IV (DPP IV) Activity and Decreased DPP IV Activity of Visceral But Not Subcutaneous Adipose Tissue in Impaired Glucose Tolerance Rats Induced by High-Fat or High-Sucrose Diet
Yasushi Kirno et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2009)
Dipeptidyl Peptidase-4 (CD26): Knowing the Function before Inhibiting the Enzyme
E. Matteucci et al.
CURRENT MEDICINAL CHEMISTRY (2009)
A long-acting glucagon-like peptide-1 analogue attenuates induction of plasminogen activator inhibitor type-1 and vascular adhesion molecules
Hongbin Liu et al.
JOURNAL OF ENDOCRINOLOGY (2009)
Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways
Kiwon Ban et al.
CIRCULATION (2008)
The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes
Daniel J. Drucker et al.
LANCET (2006)
Attractin, a dipeptidyl peptidase IV/CD26-like enzyme, is expressed on human peripheral blood monocytes and potentially influences monocyte function
Sabine Wrenger et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic Hyperglycemia in patients with type 2 diabetes
L Monnier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling
S Takai et al.
HYPERTENSION RESEARCH (2005)
Significant target organs for hypertension and cardiac hypertrophy by angiotensin-converting enzyme inhibitors
S Takai et al.
HYPERTENSION RESEARCH (2004)
Role of incretin hormones in the regulation of insulin secretion in diabetic and nondiabetic humans
JJ Holst et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease
T Nyström et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2004)
Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients -: Variations with increasing levels of HbA1c
L Monnier et al.
DIABETES CARE (2003)
Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans - Role of oxidative stress
K Esposito et al.
CIRCULATION (2002)
Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation -: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin
M Christ et al.
DIABETES (2002)
Vasorelaxant effect of glucagon-like peptide-(7-36) amide and amylin on the pulmonary circulation of the rat
HA Golpon et al.
REGULATORY PEPTIDES (2001)
分享论文
